C3.ai (AI) faces significant business struggles, with sharp revenue and margin declines, management transition, and customer ...
Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback